Company intelligence / Profile preview

Fulgent Oncology

Alpharetta, Georgia, USAfulgentoncology.com ↗

Ownership: Private
Employees: ~196
Development stage: Commercial

Overview

CSI/Fulgent Oncology provides comprehensive cancer diagnostic testing using advanced molecular and cellular techniques. They offer rapid turnaround times for flow cytometry, cytogenetics, immunohistochemistry, molecular genetics/genomics—including next-generation sequencing panels for hematologic cancers and solid tumors. Their partnership with Genomic Testing Cooperative expanded their NGS capabilities to include large gene panels for liquid biopsy applications.

Therapeutic areas: Oncology
Industry: Molecular Diagnostics

Partnerships

Genomic Testing Cooperative

Beyond the preview

Go deeper on Fulgent Oncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fulgent Oncology.

Explore the full profile